Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury

Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury

US Patent 6121231 · Granted Sep 19, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Prevention and/or treatment of hearing loss or impairment2023
Prevention and/or treatment of hearing loss or impairment2020
Mutation within the connexin 26 gene responsible for prelingual non-syndromic de2018
Mutation within the connexin 26 gene responsible for prelingual non-syndromic de2015
Mutation within the connexin 26 gene responsible for prelingual non-syndromic de2013
Mutation within the connexin 26 gene responsible for prelingual non-syndromic de2012
Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions2011
Method for inducing selected useful activities of IL-2 in a patient with peptide2010
Method of inducing SHC phosphorylation of inducing the SHC/MAPK pathway by admin2010
Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions2008
Mutation within the connexin 26 gene responsible for prelingual non-syndromic de2007
Peptides of IL-22006